Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BCEL
|
William Hewitt Robinson
Director |
SELL
Open market or private sale
|
Direct | 2,741 Reduced 0.71% |
$41,252
$15.05 p/Share
|
Jan 13
2021 |
|
XERS
|
Steven Prestrelski
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.4% |
$60,100
$6.01 p/Share
|
Jan 13
2021 |
|
NCNO
|
Jeffrey W Lunsford |
SELL
Open market or private sale
|
Direct | 24,495 Reduced 8.42% |
$1,724,203
$70.39 p/Share
|
Jan 13
2021 |
|
EIDX
|
Uma Sinha
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.16% |
$1,238,900
$123.89 p/Share
|
Jan 13
2021 |
|
SIEN
|
Caroline F. Van Hove
Director |
SELL
Open market or private sale
|
Direct | 1,973 Reduced 1.37% |
$9,293
$4.71 p/Share
|
Jan 13
2021 |
|
OGEN
|
Joseph Hernandez
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 257,510 Reduced 22.82% |
$206,008
$0.8 p/Share
|
Jan 13
2021 |
|
AFRM
|
Gic Private LTD |
SELL
Open market or private sale
|
Direct | 4,635 Reduced 37.58% |
$441,484
$95.25 p/Share
|
Jan 13
2021 |
|
CVSI
|
Michael Joseph Mona Jr
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 4.93% |
$61,000
$0.61 p/Share
|
Jan 13
2021 |
|
CFB
|
David L. O'Toole
CHIEF INVESTMENT OFFICER |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.44% |
$5,920
$11.84 p/Share
|
Jan 13
2021 |
|
RNST
|
James W Gray
Executive Vice President |
SELL
Open market or private sale
|
Indirect | 2 Reduced 100.0% |
$74
$37.2 p/Share
|
Jan 13
2021 |
|
LOV
|
David Khalil
Director |
SELL
Open market or private sale
|
Indirect | 523 Reduced 0.03% |
$3,033
$5.8 p/Share
|
Jan 13
2021 |
|
CBDS
|
David Tobias
CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.3% |
$6,200
$0.62 p/Share
|
Jan 13
2021 |
|
ICCH
|
Rock Island Investors, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 3,903 Reduced 0.98% |
$55,618
$14.25 p/Share
|
Jan 13
2021 |
|
BLFS
|
Marcus Schulz
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.11% |
$82,020
$41.01 p/Share
|
Jan 12
2021 |
|
GNK
|
Strategic Value Partners, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,403,700 Reduced 77.71% |
$35,758,043
$8.12 p/Share
|
Jan 12
2021 |
|
AN
|
Edward S Lampert |
SELL
Open market or private sale
|
Direct | 2,329 Reduced 0.02% |
$181,615
$77.98 p/Share
|
Jan 12
2021 |
|
AN
|
Edward S Lampert |
SELL
Open market or private sale
|
Indirect | 28,249 Reduced 1.39% |
$2,202,857
$77.98 p/Share
|
Jan 12
2021 |
|
CIFR
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.87% |
$204,000
$10.2 p/Share
|
Jan 12
2021 |
|
UBER
|
Dara Khosrowshahi
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 84,918 Reduced 8.51% |
$4,707,005
$55.43 p/Share
|
Jan 12
2021 |
|
MAA
|
Albert M Campbell Iii
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 397 Reduced 0.6% |
$49,033
$123.51 p/Share
|
Jan 12
2021 |
|
MAA
|
Melanie Carpenter
EVP & CHRO |
SELL
Open market or private sale
|
Direct | 208 Reduced 1.29% |
$25,690
$123.51 p/Share
|
Jan 12
2021 |
|
MAA
|
Robert J. Del Priore
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 497 Reduced 0.97% |
$61,384
$123.51 p/Share
|
Jan 12
2021 |
|
MAA
|
H Eric Bolton Jr
President and CEO |
SELL
Open market or private sale
|
Direct | 1,376 Reduced 0.51% |
$169,950
$123.51 p/Share
|
Jan 12
2021 |
|
MAA
|
Thomas L Grimes Jr
EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 406 Reduced 0.54% |
$50,145
$123.51 p/Share
|
Jan 12
2021 |
|
PLMR
|
Heath A Fisher
President |
SELL
Open market or private sale
|
Indirect | 9,877 Reduced 3.78% |
$990,762
$100.31 p/Share
|
Jan 12
2021 |
|
RGNX
|
Patrick J. Christmas
Chief Strategy & Legal Officer |
SELL
Open market or private sale
|
Direct | 1,378 Reduced 7.76% |
$67,729
$49.15 p/Share
|
Jan 12
2021 |
|
RDFN
|
Adam Wiener
President of Real Estate Ops. |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 5.16% |
$1,200,150
$80.01 p/Share
|
Jan 12
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.65% |
$246,900
$8.23 p/Share
|
Jan 12
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.65% |
$246,900
$8.23 p/Share
|
Jan 12
2021 |
|
CABA
|
5 Am Ventures V, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 85,000 Reduced 2.77% |
$1,105,000
$13.0 p/Share
|
Jan 12
2021 |
|
IDRA
|
John J. Kirby
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,693 Reduced 4.76% |
$7,144
$4.22 p/Share
|
Jan 12
2021 |
|
IDRA
|
Elizabeth Ann Tarka
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,745 Reduced 8.73% |
$7,312
$4.19 p/Share
|
Jan 12
2021 |
|
IDRA
|
Bryant David Lim
SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 1,711 Reduced 4.3% |
$7,203
$4.21 p/Share
|
Jan 12
2021 |
|
IDRA
|
Vincent Milano |
SELL
Open market or private sale
|
Direct | 3,210 Reduced 1.52% |
$13,482
$4.2 p/Share
|
Jan 12
2021 |
|
ARWR
|
Kenneth Allen Myszkowski
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,441 Reduced 0.32% |
$116,721
$81.0 p/Share
|
Jan 12
2021 |
|
PI
|
Chris Ph.D. Diorio
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.66% |
$542,200
$54.22 p/Share
|
Jan 12
2021 |
|
PI
|
Chris Ph.D. Diorio
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 9,280 Reduced 0.68% |
$501,120
$54.0 p/Share
|
Jan 12
2021 |
|
BKE
|
Robert M Carlberg
SVP MEN'S MERCHANDISING |
SELL
Open market or private sale
|
Direct | 8,500 Reduced 8.29% |
$293,250
$34.5 p/Share
|
Jan 12
2021 |
|
MLAB
|
John Bradley Schmieder
Director |
SELL
Open market or private sale
|
Direct | 477 Reduced 0.65% |
$136,055
$285.23 p/Share
|
Jan 12
2021 |
|
AOSL
|
Mike F Chang
Chairman of Board |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.47% |
$577,800
$28.89 p/Share
|
Jan 12
2021 |
|
SCHW
|
Jonathan M. Craig
MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect | 3,503 Reduced 100.0% |
$213,613
$60.98 p/Share
|
Jan 12
2021 |
|
STAA
|
Broadwood Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 0.56% |
$5,356,800
$89.28 p/Share
|
Jan 12
2021 |
|
STAA
|
Broadwood Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Jan 12
2021 |
|
MODN
|
Timothy M Adams
Director |
SELL
Open market or private sale
|
Direct | 8,119 Reduced 20.22% |
$320,376
$39.46 p/Share
|
Jan 12
2021 |
|
ABTX
|
Roland L. Williams
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.88% |
$73,640
$36.82 p/Share
|
Jan 12
2021 |
|
ADAP
|
William C Bertrand Jr
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,234 Reduced 37.22% |
$13,739
$6.15 p/Share
|
Jan 12
2021 |
|
ADAP
|
John Lunger
Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct | 1,058 Reduced 37.45% |
$6,507
$6.15 p/Share
|
Jan 12
2021 |
|
ADAP
|
Elliot Norry
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 841 Reduced 37.59% |
$5,172
$6.15 p/Share
|
Jan 12
2021 |
|
ADAP
|
Adrian Rawcliffe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,707 Reduced 42.28% |
$16,648
$6.15 p/Share
|
Jan 12
2021 |
|
AIR
|
David P Storch
Director |
SELL
Open market or private sale
|
Direct | 29,793 Reduced 11.27% |
$1,159,246
$38.91 p/Share
|
Jan 12
2021 |